Medicine composition for controlling poultry gizzard erosion diseases

The technology of gizzard erosion and composition is applied in the field of pharmaceutical composition and preparation thereof for prevention and treatment of chicken gizzard erosion disease, which can solve the problems of strong subjectivity and incomplete treatment, and achieve easy acquisition, prevention of bleeding, and convenient use Effect

Inactive Publication Date: 2012-04-04
RINGPU TIANJIN BIOLOGICAL PHARMA
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The main reason is that local veterinarians treat and prevent diseases based on past experience, which often has the problem of strong subjectivity and incomplete treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for controlling poultry gizzard erosion diseases
  • Medicine composition for controlling poultry gizzard erosion diseases
  • Medicine composition for controlling poultry gizzard erosion diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Composition: Baiji 5kg

[0040] Modified nano-montmorillonite 20kg

[0041] Cimetidine 0.1kg

[0042] Methionine 1kg

[0043] Anhydrous glucose 73.9kg

[0044] Preparation:

[0045] 1. Take anhydrous glucose, crush it, and pass through an 80-mesh sieve;

[0046] 2. Take white and decoction pieces, after selection, dry, crush, and pass through 80-mesh sieve;

[0047] 3, dilute methionine three times with anhydrous glucose equivalent incremental dilution method, cross 60 mesh fine sieves, obtain a kind of substantially mixed mixture; Dilute cimetidine six times with anhydrous glucose equivalent incremental dilution method, pass through 60 mesh fine sieve, obtain another kind of substantially homogeneous mixture.

[0048] 4. Add the above mixture, other ingredients and anhydrous glucose into the mixer, and mix for 30 minutes to obtain the product.

Embodiment 2

[0050] Composition: Baiji 8kg

[0051] Modified nano montmorillonite 12kg

[0052] Cimetidine 0.5kg

[0053] Methionine 0.1kg

[0054] Starch 79.4kg

[0055] Preparation:

[0056] 1. Take white and decoction pieces, after selection, dry, crush, and pass through 80-mesh sieve;

[0057] 2. Dilute methionine six times with starch equivalent incremental dilution method, and pass through a 60-mesh fine sieve to obtain a basically evenly mixed mixture.

[0058]3. Dilute cimetidine six times with starch equivalent incremental dilution method, and pass through a 60-mesh fine sieve to obtain a substantially homogeneous mixture.

[0059] 4. Add the above two mixtures, other ingredients and starch into the mixer, and mix for 30 minutes to get the product.

Embodiment 3

[0061] Composition: Baiji 10kg

[0062] Modified nano-montmorillonite 5kg

[0063] Cimetidine 2kg

[0064] Methionine 0.5kg

[0065] Xylooligosaccharide 74.5kg

[0066] Preparation:

[0067] 1. Take white and decoction pieces, after selection, dry, crush, and pass through 80-mesh sieve;

[0068] 2. Dilute methionine three times with xylo-oligosaccharide equal amount incremental dilution method, and pass through a 60-mesh fine sieve to obtain a basically evenly mixed mixture.

[0069] 3. Add the above mixture, other ingredients and starch into the mixer, mix for 30 minutes, and the product is ready.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicine composition for controlling poultry gizzard erosion diseases, comprising the following ingredients: rhizoma bletillae powder, modified nano montmorillonite, cimetidine, methionine, and pharmaceutic adjuvant. The medicine composition has the effects of protecting gastric mucosa, promoting the mucosa healing, prevent harmful substance from damaging mucosa, improving hepatic/renal function, cooling blood, stop bleeding, eliminating stasis, and engendering flesh, and provides a feasible approach for industrial production.

Description

technical field [0001] The invention belongs to the technical field of veterinary medicine, and in particular relates to a pharmaceutical composition for preventing and treating chicken gizzard erosion disease and a preparation method thereof. Background technique [0002] Poultry gizzard erosion is a digestive tract disease caused by a variety of pathogenic factors in poultry gizzard cuticle erosions and ulcers. It is a non-infectious disease similar to gastrointestinal ulcer bleeding in mammals and humans. . Poultry gizzard erosion mainly occurs in broiler chickens, followed by laying hens and ducks. The age of onset is from 2 weeks to 2.5 months. The clinical diagnosis of gizzard erosion in poultry is characterized by loss of appetite, mental fatigue, severe cases of vomiting black matter, anemia and emaciation, so it was once called "black vomiting disease". [0003] 1. Predisposing factors [0004] In the initial stage of the disease discovery, its etiology is still ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/898A61K36/739A61K36/489A61P1/04A61K31/14A61K31/198A61K31/357A61K31/4164A61K33/06
Inventor 夏雪林刘桂兰王爱萍刘爱玲
Owner RINGPU TIANJIN BIOLOGICAL PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap